IBDEI312 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48345,1,4,0)
 ;;=4^R39.0
 ;;^UTILITY(U,$J,358.3,48345,2)
 ;;=^5019340
 ;;^UTILITY(U,$J,358.3,48346,0)
 ;;=N93.9^^185^2420^131
 ;;^UTILITY(U,$J,358.3,48346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48346,1,3,0)
 ;;=3^Uterine/Vaginal Bleeding,Abnormal,Unspec
 ;;^UTILITY(U,$J,358.3,48346,1,4,0)
 ;;=4^N93.9
 ;;^UTILITY(U,$J,358.3,48346,2)
 ;;=^5015916
 ;;^UTILITY(U,$J,358.3,48347,0)
 ;;=N85.9^^185^2420^133
 ;;^UTILITY(U,$J,358.3,48347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48347,1,3,0)
 ;;=3^Uterus Noninflammatory Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48347,1,4,0)
 ;;=4^N85.9
 ;;^UTILITY(U,$J,358.3,48347,2)
 ;;=^5015873
 ;;^UTILITY(U,$J,358.3,48348,0)
 ;;=N71.9^^185^2420^132
 ;;^UTILITY(U,$J,358.3,48348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48348,1,3,0)
 ;;=3^Uterus Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,48348,1,4,0)
 ;;=4^N71.9
 ;;^UTILITY(U,$J,358.3,48348,2)
 ;;=^5015811
 ;;^UTILITY(U,$J,358.3,48349,0)
 ;;=N76.89^^185^2420^135
 ;;^UTILITY(U,$J,358.3,48349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48349,1,3,0)
 ;;=3^Vagina/Vulva Inflammation,Other Spec
 ;;^UTILITY(U,$J,358.3,48349,1,4,0)
 ;;=4^N76.89
 ;;^UTILITY(U,$J,358.3,48349,2)
 ;;=^5015833
 ;;^UTILITY(U,$J,358.3,48350,0)
 ;;=N89.9^^185^2420^134
 ;;^UTILITY(U,$J,358.3,48350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48350,1,3,0)
 ;;=3^Vagina Noninflammatory Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48350,1,4,0)
 ;;=4^N89.9
 ;;^UTILITY(U,$J,358.3,48350,2)
 ;;=^5015890
 ;;^UTILITY(U,$J,358.3,48351,0)
 ;;=N76.0^^185^2420^136
 ;;^UTILITY(U,$J,358.3,48351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48351,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,48351,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,48351,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,48352,0)
 ;;=N76.1^^185^2420^137
 ;;^UTILITY(U,$J,358.3,48352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48352,1,3,0)
 ;;=3^Vaginitis,Subacute/Chronic
 ;;^UTILITY(U,$J,358.3,48352,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,48352,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,48353,0)
 ;;=N90.9^^185^2420^138
 ;;^UTILITY(U,$J,358.3,48353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48353,1,3,0)
 ;;=3^Vulva/Perineum Noninflammaotory Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48353,1,4,0)
 ;;=4^N90.9
 ;;^UTILITY(U,$J,358.3,48353,2)
 ;;=^5015901
 ;;^UTILITY(U,$J,358.3,48354,0)
 ;;=N39.491^^185^2420^22
 ;;^UTILITY(U,$J,358.3,48354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48354,1,3,0)
 ;;=3^Coital Incontinence
 ;;^UTILITY(U,$J,358.3,48354,1,4,0)
 ;;=4^N39.491
 ;;^UTILITY(U,$J,358.3,48354,2)
 ;;=^5138920
 ;;^UTILITY(U,$J,358.3,48355,0)
 ;;=N39.492^^185^2420^82
 ;;^UTILITY(U,$J,358.3,48355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48355,1,3,0)
 ;;=3^Postural Urinary Incontinence
 ;;^UTILITY(U,$J,358.3,48355,1,4,0)
 ;;=4^N39.492
 ;;^UTILITY(U,$J,358.3,48355,2)
 ;;=^5138921
 ;;^UTILITY(U,$J,358.3,48356,0)
 ;;=N42.30^^185^2420^26
 ;;^UTILITY(U,$J,358.3,48356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48356,1,3,0)
 ;;=3^Dysplasia of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,48356,1,4,0)
 ;;=4^N42.30
 ;;^UTILITY(U,$J,358.3,48356,2)
 ;;=^5138924
 ;;^UTILITY(U,$J,358.3,48357,0)
 ;;=N50.811^^185^2420^102
 ;;^UTILITY(U,$J,358.3,48357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48357,1,3,0)
 ;;=3^Testicular Pain,Right
 ;;^UTILITY(U,$J,358.3,48357,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,48357,2)
 ;;=^5138927
